Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

Clinical trial NCT06802315 · RECRUITING

Trial details

NCT number: NCT06802315
Sponsor: University of Illinois at Chicago
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, Relapsed, Adult Acute Myeloid Leukemia Refractory Chronic Myeloid Leukemia - Accelerated Phase Myelodysplastic Syndromes

Start date: 2025-02-04
Primary completion: 2030-03-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.